American Scientific Resources, Incorporated (ASFX) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
American Scientific Resources, Incorporated (ASFX) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026American Scientific Resources, Incorporated (ASFX) Resumen de Asistencia Médica y Tuberías
American Scientific Resources, Incorporated, currently in liquidation, formerly operated in the medical instruments and supplies sector, focusing on developing and distributing products for both children and adults. Its product line included thermometers, respiratory devices, and other healthcare aids, primarily distributed through retail channels and online platforms. The company was based in Weston, Florida.
Tesis de Inversión
American Scientific Resources, Incorporated presents a complex investment case due to its current liquidation status. The company's past focus on developing and distributing medical devices for children and adults suggests a potential market opportunity, but its financial instability and subsequent liquidation significantly undermine any investment appeal. The company's negative free cash flow of $-0.00B and a market capitalization of $0.00B further highlight its distressed state. While its products once addressed specific needs in the healthcare market, the liquidation process raises substantial concerns about asset recovery and potential returns for investors. The company's beta of -3.31 may indicate low volatility, but this is largely irrelevant given its liquidation status.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B reflects the company's liquidation status and lack of active trading.
- Gross Margin of 21.5% indicates the profitability of products before liquidation, but is not indicative of current financial health.
- Free Cash Flow of $-0.00B highlights the company's financial struggles leading to liquidation.
- Beta of -3.31 suggests a low correlation with the market, but is not a relevant metric given the company's current state.
- Liquidation status indicates significant financial distress and potential loss of investment.
Competidores y Pares
Fortalezas
- N/A: Given the company's liquidation status, it no longer possesses any strengths.
Debilidades
- Liquidation status
- Financial instability
- Lack of ongoing operations
Catalizadores
- N/A: The company is in liquidation.
Riesgos
- Ongoing: Liquidation process may result in complete loss of investment.
- Ongoing: Lack of financial transparency due to OTC Other status.
- Ongoing: Minimal trading volume and liquidity.
Oportunidades de crecimiento
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
Oportunidades
- N/A: Given the company's liquidation status, it has no opportunities.
Amenazas
- N/A: Given the company's liquidation status, it faces no threats.
Ventajas competitivas
- N/A: Given the company's liquidation status, it no longer possesses a sustainable competitive advantage or 'moat'.
Acerca de ASFX
American Scientific Resources, Incorporated was a developer, manufacturer, and distributor of medical products and devices aimed at both children and adults. Founded with the mission of providing innovative healthcare solutions, the company offered a diverse portfolio of products designed to address various needs within the healthcare market. Its product lineup included the Thermofocus 5-in-1 non-contact clinical thermometer, VeraTemp and VeraTemp+ non-contact thermometers, and the Scald Safe Water temperature disc, designed to prevent scalding in baby baths. Additionally, the company offered WhistleWatch, a flow monitoring device for children with respiratory issues, and the Kidz-Med portable ultrasonic nebulizer for treating conditions like asthma and bronchitis. Further expanding its product range, American Scientific Resources provided the Kidz-Med Medicine Dispenser, the Kidz-Med Mommy Recorder, Bip DVDs, the Mebby product line (including breast pumps and baby bottles), and Wee Target. The company also offered the Disintegrator, a home needle and lancet destruction device. Distribution was primarily achieved through retail drug and grocery chains, medical suppliers, its own website, and other online platforms. However, on February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against the company, and the petition was approved on March 28, 2012. As of 2026, American Scientific Resources, Inc. is in liquidation.
Qué hacen
- Developed and manufactured medical products for children and adults.
- Offered non-contact clinical thermometers.
- Provided respiratory monitoring devices.
- Developed devices for safe baby care, such as bath water temperature discs.
- Distributed products through retail drug and grocery chains.
- Sold products through its website and online platforms.
Modelo de Negocio
- Developed and manufactured medical devices.
- Distributed products through retail and online channels.
- Generated revenue through product sales.
Contexto de la Industria
American Scientific Resources, Incorporated operated within the medical instruments and supplies industry, a sector characterized by continuous innovation and stringent regulatory oversight. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements in medical devices. Competitors in this space, such as CEVE, HCANF, HSMD, LOWLF, and MDIT, operate in a dynamic environment where product differentiation and regulatory compliance are critical for success. However, given American Scientific Resources' liquidation status, it no longer actively participates in or influences the competitive landscape.
Clientes Clave
- Parents and caregivers of infants and children.
- Adults requiring medical devices for personal health monitoring.
- Retail drug and grocery chains.
- Medical suppliers.
Finanzas
Gráfico e información
Precio de la acción de American Scientific Resources, Incorporated (ASFX): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para ASFX.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ASFX.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para ASFX.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ASFX en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Información del mercado OTC de ASFX
The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or have chosen not to provide current information to the market. These securities are often speculative and carry a high degree of risk due to the limited information available and the potential for fraud or manipulation. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face minimal listing requirements, resulting in greater uncertainty for investors. This tier includes companies in bankruptcy, liquidation, or those with questionable business operations.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited or no financial disclosure
- High potential for fraud or manipulation
- Low liquidity and wide bid-ask spreads
- Bankruptcy or liquidation status
- Lack of regulatory oversight
- Verify the company's liquidation status with the US Bankruptcy Court for the Southern District of Florida.
- Review any available financial reports, if any exist.
- Assess the potential for asset recovery in liquidation.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC Other securities.
- Check for any regulatory actions or legal proceedings against the company.
- N/A: Given the company's liquidation status, there are no legitimacy signals.
ASFX Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar ASFX?
American Scientific Resources, Incorporated (ASFX) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Riesgo principal a monitorear: Ongoing: Liquidation process may result in complete loss of investment.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ASFX?
ASFX actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ASFX?
Los precios de ASFX se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ASFX?
La cobertura de analistas para ASFX incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ASFX?
Las categorías de riesgo para ASFX incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Liquidation process may result in complete loss of investment.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ASFX?
La relación P/E para ASFX compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ASFX sobrevalorada o infravalorada?
Determinar si American Scientific Resources, Incorporated (ASFX) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ASFX?
American Scientific Resources, Incorporated (ASFX) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available historical data and the company's liquidation status.
- The company is in liquidation, which significantly impacts its financial viability and investment potential.